Use of 4-pyridylmethylphthalazines for cancer treatment

Details for Australian Patent Application No. 2006203428 (hide)

Owner Novartis AG

Inventors Wood, Jeanette Marjorie; Dugan, Margaret Han

Agent Davies Collison Cave

Pub. Number AU-B-2006203428

Parent 2002342678

Filing date 9 August 2006

Wipo publication date 31 August 2006

Acceptance publication date 4 June 2009

International Classifications

A61K 31/50 (2006.01) - Pyridazines

Event Publications

24 August 2006 Complete Application Filed

31 August 2006 Application Open to Public Inspection

  Published as AU-B-2006203428

4 June 2009 Application Accepted

  Published as AU-B-2006203428

1 October 2009 Standard Patent Sealed

7 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203429-OPG Fusion Protein Compositions and Methods

2006203427-Infusion Packet with Useful and Decorative Elements, Support Member, Delivery System and Method